Katerina Jerabkova-Roda
Research Subjects
Katerina Jerabkova-Roda has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Jacky G. Goetz
Tumor Biomechanics lab, Strasbourg, France; INSERM UMR_S1109, Strasbourg, France; Université de Strasbourg, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France; Equipe Labellisée Ligue Contre le Cancer, Strasbourg, France
9 shared publications - Vincent Hyenne
Tumor Biomechanics Lab, Inserm UMRS1109
7 shared publications - Angélique Pichot
Immunology and Hematology Research Center, Strasbourg Research Center in Biomedicine (CRBS), Strasbourg Federation of Translational Medicine (FMTS), School of Medicine, University of Strasbourg 1 Molecular Immuno-Rheumatology Laboratory (IRM), INSERM UMR_S 1109, GENOMAX-CYTOMAX Platforms Strasbourg
5 shared publications Ignacio Busnelli
Tumor Biomechanics Lab, INSERM UMR_S1109, Strasbourg, France
5 shared publications- Izabela Sumara
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
5 shared publications - Raphael Carapito
Laboratoire d’ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, Strasbourg, France
5 shared publications
Latest Publications
- 25 October 2026
- Published by Springer Nature
- Vol. 3089, 251-264
Quantitative Mapping of Organelle Positioning in Cultured Cells Using Semi-Automated Image Analysis Pipeline
Subcellular architecture is tightly controlled and contributes to the maintenance of cell homeostasis. Organelles are regulated in size, shape, number, and position, all of which respond to changes in the extracellular environment. Lysosomes are of particular interest as they integrate various functions in the cells (nutrient sensing, metabolism, cell migration, and adhesion), serving as signaling hubs. Their function is tightly linked to their subcellular position, and deregulation of lysosome homeostasis leads to several diseases, including cancer. Therefore, methods allowing precise analysis of organelle subcellular distribution can aid in fundamental, diagnostic, and therapeutic approaches. Here, we provide a versatile image analysis pipeline using ImageJ and CellProfiler. This workflow allows for the quantification of subcellular lysosome distribution in living and fixed melanoma cells, and it is applicable to other subcellular compartments and to various cell types.
- 25 October 2026
- Published by Springer Nature
- Vol. 3089, 251-264
Quantitative Mapping of Organelle Positioning in Cultured Cells Using Semi-Automated Image Analysis Pipeline
Subcellular architecture is tightly controlled and contributes to the maintenance of cell homeostasis. Organelles are regulated in size, shape, number, and position, all of which respond to changes in the extracellular environment. Lysosomes are of particular interest as they integrate various functions in the cells (nutrient sensing, metabolism, cell migration, and adhesion), serving as signaling hubs. Their function is tightly linked to their subcellular position, and deregulation of lysosome homeostasis leads to several diseases, including cancer. Therefore, methods allowing precise analysis of organelle subcellular distribution can aid in fundamental, diagnostic, and therapeutic approaches. Here, we provide a versatile image analysis pipeline using ImageJ and CellProfiler. This workflow allows for the quantification of subcellular lysosome distribution in living and fixed melanoma cells, and it is applicable to other subcellular compartments and to various cell types.
- Open Access
- 22 September 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (11) , 4260-4299
Pharmacological inhibition of UBASH3B induces mitotic arrest and selectively reduces tumor growth
Cancer cells tolerate mitotic errors to sustain proliferation, yet the molecular dependencies enabling this tolerance remain poorly understood and largely unexploited therapeutically. UBASH3B ensures mitotic fidelity by regulating Aurora B localization and is overexpressed in tumors. We investigated whether pharmacological disruption of this pathway exposes a mitotic dependency in cancer. We demonstrate that the UBASH3B 2HP domain represents a druggable interface for disrupting UBASH3B-dependent Aurora B regulation. We identify UBASHIN, a small-molecule inhibitor targeting this domain. UBASHIN phenocopies UBASH3B depletion, causing Aurora B mislocalization, mitotic arrest and mitotic cell death. UBASHIN impairs UBASH3B localization to the mitotic spindle and selectively inhibits cancer cell proliferation while sparing non-cancerous cells. UBASH3B protein levels and the cellular ability to sustain mitotic arrest, but not global aneuploidy, predict UBASHIN sensitivity, supporting a cancer-specific on-target mechanism. In colorectal and triple-negative breast cancer mouse models, UBASHIN reduces tumor volume comparably to docetaxel, without detectable toxicity in wild-type animals. These findings identify the UBASH3B pathway as a cancer-specific mitotic vulnerability and highlight its pharmacological inhibition as a selective therapeutic strategy.
- 22 September 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (11) , 4260-4299
Open AccessPharmacological inhibition of UBASH3B induces mitotic arrest and selectively reduces tumor growth
Cancer cells tolerate mitotic errors to sustain proliferation, yet the molecular dependencies enabling this tolerance remain poorly understood and largely unexploited therapeutically. UBASH3B ensures mitotic fidelity by regulating Aurora B localization and is overexpressed in tumors. We investigated whether pharmacological disruption of this pathway exposes a mitotic dependency in cancer. We demonstrate that the UBASH3B 2HP domain represents a druggable interface for disrupting UBASH3B-dependent Aurora B regulation. We identify UBASHIN, a small-molecule inhibitor targeting this domain. UBASHIN phenocopies UBASH3B depletion, causing Aurora B mislocalization, mitotic arrest and mitotic cell death. UBASHIN impairs UBASH3B localization to the mitotic spindle and selectively inhibits cancer cell proliferation while sparing non-cancerous cells. UBASH3B protein levels and the cellular ability to sustain mitotic arrest, but not global aneuploidy, predict UBASHIN sensitivity, supporting a cancer-specific on-target mechanism. In colorectal and triple-negative breast cancer mouse models, UBASHIN reduces tumor volume comparably to docetaxel, without detectable toxicity in wild-type animals. These findings identify the UBASH3B pathway as a cancer-specific mitotic vulnerability and highlight its pharmacological inhibition as a selective therapeutic strategy.
- Open Access
Quantitative Mapping of Organelle Positioning in Cultured Cells Using Semi-Automated Image Analysis Pipeline
Subcellular architecture is tightly controlled and contributes to the maintenance of cell homeostasis. Organelles are regulated in size, shape, number and position which respond to changes in extracellular environment. Lysosomes are of particular interest as they integrate various functions in the cells (nutrient sensing, metabolism, cell migration and adhesion), serving as signaling hubs. Their function is tightly linked to their subcellular position and deregulation of lysosome homeostasis leads to several diseases including cancer. Therefore, methods allowing precise analysis of organelle subcellular distribution can aid in fundamental, diagnostic and therapeutic approaches. Here, we provide a versatile image analysis pipeline using ImageJ and CellProfiler. This workflow allows to quantify subcellular lysosome distribution in living and fixed melanoma cells, and is applicable to other subcellular compartments and to various cell types.
Open AccessQuantitative Mapping of Organelle Positioning in Cultured Cells Using Semi-Automated Image Analysis Pipeline
Subcellular architecture is tightly controlled and contributes to the maintenance of cell homeostasis. Organelles are regulated in size, shape, number and position which respond to changes in extracellular environment. Lysosomes are of particular interest as they integrate various functions in the cells (nutrient sensing, metabolism, cell migration and adhesion), serving as signaling hubs. Their function is tightly linked to their subcellular position and deregulation of lysosome homeostasis leads to several diseases including cancer. Therefore, methods allowing precise analysis of organelle subcellular distribution can aid in fundamental, diagnostic and therapeutic approaches. Here, we provide a versatile image analysis pipeline using ImageJ and CellProfiler. This workflow allows to quantify subcellular lysosome distribution in living and fixed melanoma cells, and is applicable to other subcellular compartments and to various cell types.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation
Les rôles de Trim15 et UCHL3 dans la régulation, médiée par l’ubiquitine, du cycle cellulaire: La mitose est précisément contrôlée par la signalisation via l'ubiquitine et est essentielle au maintien de l'intégrité du génome. Dans ce travail, j'ai étudié la fonction de l'enzyme de dé-ubiquitination, UCHL3 et de la ligase E3-ubiquitine, TRIM15. J'ai observé que TRIM15 régule l'adhésion et la mobilité des cellules. UCHL3 a été identifié par un criblage à haut contenu, en tant que facteur critique contrôlant l'alignement et la ségrégation des chromosomes. Fait intéressant, il a déjà été rapporté que les niveaux d’expression d’UCHL3 sont altérés dans divers types de cancer. En utilisant une approche protéomique, nous avons identifié la kinase Aurora B comme un médiateur potentiel de ces phénotypes. Comme l'aneuploïdie est la marque de nombreux cancers et que l'adhésion cellulaire joue un rôle important dans l'invasion des tumeurs et les métastases, mes résultats suggèrent que ces deux protéines pourraient jouer un rôle dans la carcinogenèse.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation
Les rôles de Trim15 et UCHL3 dans la régulation, médiée par l’ubiquitine, du cycle cellulaire: La mitose est précisément contrôlée par la signalisation via l'ubiquitine et est essentielle au maintien de l'intégrité du génome. Dans ce travail, j'ai étudié la fonction de l'enzyme de dé-ubiquitination, UCHL3 et de la ligase E3-ubiquitine, TRIM15. J'ai observé que TRIM15 régule l'adhésion et la mobilité des cellules. UCHL3 a été identifié par un criblage à haut contenu, en tant que facteur critique contrôlant l'alignement et la ségrégation des chromosomes. Fait intéressant, il a déjà été rapporté que les niveaux d’expression d’UCHL3 sont altérés dans divers types de cancer. En utilisant une approche protéomique, nous avons identifié la kinase Aurora B comme un médiateur potentiel de ces phénotypes. Comme l'aneuploïdie est la marque de nombreux cancers et que l'adhésion cellulaire joue un rôle important dans l'invasion des tumeurs et les métastases, mes résultats suggèrent que ces deux protéines pourraient jouer un rôle dans la carcinogenèse.
- Open Access
- 20 March 2026
- Published by EDP Sciences in médecine/sciences
- Vol. 42 (3) , 258-262
Quand la position des organites favorise la progression du cancer
Le développement d’une tumeur s’accompagne de changements dans le positionnement des organites intracellulaires. Parmi ceux-ci, les lysosomes, longtemps considérés comme des compartiments uniquement dégradatifs, sont désormais reconnus comme des régulateurs clés du métabolisme, de la signalisation et de l’invasion tumorale. Nous discutons ici de la manière dont leur localisation intracellulaire influence leur fonction, leur signalisation et leur sécrétion. Dans le mélanome, leur distribution périphérique favorise l’agressivité des cellules tumorales et les métastases. L’existence de changements similaires dans d’autres cancers souligne le rôle du trafic lysosomal en tant que facteur de malignité et en tant que biomarqueur prometteur pour le diagnostic et le traitement.
- 20 March 2026
- Published by EDP Sciences in médecine/sciences
- Vol. 42 (3) , 258-262
Open AccessQuand la position des organites favorise la progression du cancer
Le développement d’une tumeur s’accompagne de changements dans le positionnement des organites intracellulaires. Parmi ceux-ci, les lysosomes, longtemps considérés comme des compartiments uniquement dégradatifs, sont désormais reconnus comme des régulateurs clés du métabolisme, de la signalisation et de l’invasion tumorale. Nous discutons ici de la manière dont leur localisation intracellulaire influence leur fonction, leur signalisation et leur sécrétion. Dans le mélanome, leur distribution périphérique favorise l’agressivité des cellules tumorales et les métastases. L’existence de changements similaires dans d’autres cancers souligne le rôle du trafic lysosomal en tant que facteur de malignité et en tant que biomarqueur prometteur pour le diagnostic et le traitement.
- Open Access
Selective targeting of RalA with intrabodies impairs Triple Negative Breast Cancer metastasis
This study successfully developed and validated isoform-specific intrabodies targeting the highly homologous Ral oncoproteins, key effectors in cancer progression. Phage display was used to isolate single-chain variable fragment (scFv) clones that recognize specifically RalA (C1-A, G5-A), RalB (F6-B), or both paralogs (A12-AB). Using lentiviral transduction, these intrabodies were stably expressed as GFP fusions in murine breast cancer 4T1 cells. The anti-RalA clones C1-A and A12-AB demonstrated clear colocalization with RalA, confirming their binding activity inside the cell. We further confirmed their activity in cells by analyzing Ral-dependent pathways. All intrabodies targeting RalA (C1-A, G5-A, A12-AB) but not the one specific to RalB inhibited mitochondrial fission, a known RalA function. All clones, except the pan-Ral one, altered the endo-lysosome pathway by decreasing lysosome number. Furthermore, the RalA-specific C1-A clone reduced lysosomes size, and uniquely and strongly reduced extracellular vesicle secretion, highlighting its distinct inhibitory potential. In an orthotopic Triple-Negative Breast Cancer (TNBC) mouse model, The C1-A RalA specific clone significantly but weakly reduced primary tumor growth, but exerted a powerful anti-metastatic effect, dramatically reducing lung metastases, with a complete abolition of metastases observed in 2/5 mice. In summary, these potent, isoform-specific Ral intrabodies act as effective intracellular inhibitors, successfully modulating RalA-specific functions in cells and offering a promising therapeutic strategy for significantly suppressing tumor growth and metastasis in vivo.
Open AccessSelective targeting of RalA with intrabodies impairs Triple Negative Breast Cancer metastasis
This study successfully developed and validated isoform-specific intrabodies targeting the highly homologous Ral oncoproteins, key effectors in cancer progression. Phage display was used to isolate single-chain variable fragment (scFv) clones that recognize specifically RalA (C1-A, G5-A), RalB (F6-B), or both paralogs (A12-AB). Using lentiviral transduction, these intrabodies were stably expressed as GFP fusions in murine breast cancer 4T1 cells. The anti-RalA clones C1-A and A12-AB demonstrated clear colocalization with RalA, confirming their binding activity inside the cell. We further confirmed their activity in cells by analyzing Ral-dependent pathways. All intrabodies targeting RalA (C1-A, G5-A, A12-AB) but not the one specific to RalB inhibited mitochondrial fission, a known RalA function. All clones, except the pan-Ral one, altered the endo-lysosome pathway by decreasing lysosome number. Furthermore, the RalA-specific C1-A clone reduced lysosomes size, and uniquely and strongly reduced extracellular vesicle secretion, highlighting its distinct inhibitory potential. In an orthotopic Triple-Negative Breast Cancer (TNBC) mouse model, The C1-A RalA specific clone significantly but weakly reduced primary tumor growth, but exerted a powerful anti-metastatic effect, dramatically reducing lung metastases, with a complete abolition of metastases observed in 2/5 mice. In summary, these potent, isoform-specific Ral intrabodies act as effective intracellular inhibitors, successfully modulating RalA-specific functions in cells and offering a promising therapeutic strategy for significantly suppressing tumor growth and metastasis in vivo.
- Open Access
- 9 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Peripheral positioning of lysosomes supports melanoma aggressiveness
Emerging evidence suggests that the function and position of organelles are pivotal for tumor cell dissemination. Among them, lysosomes stand out as they integrate metabolic sensing with gene regulation and secretion of proteases. Yet, how their function is linked to their position and how this controls metastasis remains elusive. Here, we analyze lysosome subcellular distribution in patient-derived melanoma cells and patient biopsies and show that lysosome spreading scales with melanoma aggressiveness. Peripheral lysosomes promote matrix degradation and cell invasion which is directly linked to the lysosomal and cell transcriptional programs. Using chemo-genetical control of lysosome positioning, we demonstrate that perinuclear clustering impairs lysosome secretion, matrix degradation and invasion. Impairing lysosome spreading significantly reduces invasive outgrowth in two in vivo models, mouse and zebrafish. Our study provides a direct demonstration that lysosome positioning controls cell invasion, illustrating the importance of organelle adaptation in carcinogenesis and suggesting its potential utility for diagnosis of metastatic melanoma.
- 9 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessPeripheral positioning of lysosomes supports melanoma aggressiveness
Emerging evidence suggests that the function and position of organelles are pivotal for tumor cell dissemination. Among them, lysosomes stand out as they integrate metabolic sensing with gene regulation and secretion of proteases. Yet, how their function is linked to their position and how this controls metastasis remains elusive. Here, we analyze lysosome subcellular distribution in patient-derived melanoma cells and patient biopsies and show that lysosome spreading scales with melanoma aggressiveness. Peripheral lysosomes promote matrix degradation and cell invasion which is directly linked to the lysosomal and cell transcriptional programs. Using chemo-genetical control of lysosome positioning, we demonstrate that perinuclear clustering impairs lysosome secretion, matrix degradation and invasion. Impairing lysosome spreading significantly reduces invasive outgrowth in two in vivo models, mouse and zebrafish. Our study provides a direct demonstration that lysosome positioning controls cell invasion, illustrating the importance of organelle adaptation in carcinogenesis and suggesting its potential utility for diagnosis of metastatic melanoma.
- Open Access
- 13 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (37) , eado5545
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease
Inositol 1,4,5-trisphosphate (IP3) receptor type 1 ( ITPR1 ), 2 ( ITPR2 ), and 3 ( ITPR3 ) encode the IP3 receptor (IP3R), a key player in intracellular calcium release. In four unrelated patients, we report that an identical ITPR3 de novo variant—NM_002224.3:c.7570C>T, p.Arg2524Cys—causes, through a dominant-negative effect, a complex multisystemic disorder with immunodeficiency. This leads to defective calcium homeostasis, mitochondrial malfunction, CD4 + lymphopenia, a quasi-absence of naïve CD4 + and CD8 + cells, an increase in memory cells, and a distinct TCR repertoire. The calcium defect was recapitulated in Jurkat knock-in. Site-directed mutagenesis displayed the exquisite sensitivity of Arg 2524 to any amino acid change. Despite the fact that all patients had severe immunodeficiency, they also displayed variable multisystemic involvements, including ectodermal dysplasia, Charcot-Marie-Tooth disease, short stature, and bone marrow failure. In conclusion, unlike previously reported ITPR1-3 deficiencies leading to narrow, mainly neurological phenotypes, a recurrent dominant ITPR3 variant leads to a multisystemic disease, defining a unique role for IP3R3 in the tetrameric IP3R complex.
- 13 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (37) , eado5545
Open AccessA pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease
Inositol 1,4,5-trisphosphate (IP3) receptor type 1 ( ITPR1 ), 2 ( ITPR2 ), and 3 ( ITPR3 ) encode the IP3 receptor (IP3R), a key player in intracellular calcium release. In four unrelated patients, we report that an identical ITPR3 de novo variant—NM_002224.3:c.7570C>T, p.Arg2524Cys—causes, through a dominant-negative effect, a complex multisystemic disorder with immunodeficiency. This leads to defective calcium homeostasis, mitochondrial malfunction, CD4 + lymphopenia, a quasi-absence of naïve CD4 + and CD8 + cells, an increase in memory cells, and a distinct TCR repertoire. The calcium defect was recapitulated in Jurkat knock-in. Site-directed mutagenesis displayed the exquisite sensitivity of Arg 2524 to any amino acid change. Despite the fact that all patients had severe immunodeficiency, they also displayed variable multisystemic involvements, including ectodermal dysplasia, Charcot-Marie-Tooth disease, short stature, and bone marrow failure. In conclusion, unlike previously reported ITPR1-3 deficiencies leading to narrow, mainly neurological phenotypes, a recurrent dominant ITPR3 variant leads to a multisystemic disease, defining a unique role for IP3R3 in the tetrameric IP3R complex.
- 13 December 2023
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 86, 102293
Organelle morphology and positioning orchestrate physiological and disease-associated processes
- 13 December 2023
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 86, 102293
Organelle morphology and positioning orchestrate physiological and disease-associated processes
- Open Access
- 16 November 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (12) , e57042
Blood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesis
Extracellular vesicles released by tumors (tEVs) disseminate via circulatory networks and promote microenvironmental changes in distant organs favoring metastatic seeding. Despite their abundance in the bloodstream, how hemodynamics affect the function of circulating tEVs remains unsolved. We demonstrated that efficient uptake of tEVs occurs in venous endothelial cells that are subjected to hemodynamics. Low flow regimes observed in veins partially reroute internalized tEVs toward non-acidic and non-degradative Rab14-positive endosomes, at the expense of lysosomes, suggesting that endothelial mechanosensing diverts tEVs from degradation. Subsequently, tEVs promote the expression of pro-angiogenic transcription factors in low flow-stimulated endothelial cells and favor vessel sprouting in zebrafish. Altogether, we demonstrate that low flow regimes potentiate the pro-tumoral function of circulating tEVs by promoting their uptake and rerouting their trafficking. We propose that tEVs contribute to pre-metastatic niche formation by exploiting endothelial mechanosensing in specific vascular regions with permissive hemodynamics.
- 16 November 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (12) , e57042
Open AccessBlood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesis
Extracellular vesicles released by tumors (tEVs) disseminate via circulatory networks and promote microenvironmental changes in distant organs favoring metastatic seeding. Despite their abundance in the bloodstream, how hemodynamics affect the function of circulating tEVs remains unsolved. We demonstrated that efficient uptake of tEVs occurs in venous endothelial cells that are subjected to hemodynamics. Low flow regimes observed in veins partially reroute internalized tEVs toward non-acidic and non-degradative Rab14-positive endosomes, at the expense of lysosomes, suggesting that endothelial mechanosensing diverts tEVs from degradation. Subsequently, tEVs promote the expression of pro-angiogenic transcription factors in low flow-stimulated endothelial cells and favor vessel sprouting in zebrafish. Altogether, we demonstrate that low flow regimes potentiate the pro-tumoral function of circulating tEVs by promoting their uptake and rerouting their trafficking. We propose that tEVs contribute to pre-metastatic niche formation by exploiting endothelial mechanosensing in specific vascular regions with permissive hemodynamics.